As such, tumors with IDH1/2 mutations designated a diagnosis of either IDH-mutant astrocytoma or IDH-mutant secondary glioblastoma multiforme, depending on the morphologic characteristics of the tumor [5]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).